BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 10180947)

  • 1. Exit from Medicare. Intermountain, PacifiCare drop risk plans in Utah.
    Shinkman R
    Mod Healthc; 1998 Jun; 28(25):10. PubMed ID: 10180947
    [No Abstract]   [Full Text] [Related]  

  • 2. Pulling up stakes. Anthem's Ohio exit may signal Medicare risk HMO trend.
    Rauber C
    Mod Healthc; 1998 Jun; 28(24):26. PubMed ID: 10181113
    [No Abstract]   [Full Text] [Related]  

  • 3. Don't miss out on Medicare managed care.
    Terry K
    Med Econ; 1997 Apr; 74(7):58-60, 63, 68-70 passim. PubMed ID: 10165907
    [No Abstract]   [Full Text] [Related]  

  • 4. PSO notice to providers: Uncle Sam wants you.
    Manag Care Strateg; 1998 Jun; 6(6):61-3. PubMed ID: 10181410
    [No Abstract]   [Full Text] [Related]  

  • 5. Provider sponsored organizations: opportunity or regulatory quagmire?
    Krasner WL
    Manag Care Q; 1997; 5(4):65-8. PubMed ID: 10175723
    [No Abstract]   [Full Text] [Related]  

  • 6. Will PSOs be a disaster or a dream?
    Jaklevic MC
    Mod Healthc; 1998 Jun; 28(24):58-60. PubMed ID: 10181120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Providers could find pot of gold by pursuing the right Medicare contracting alternative.
    Public Sect Contract Rep; 1998 Mar; 4(3):41-5. PubMed ID: 10177851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medicare's new capitation method.
    Grimaldi P
    J Health Care Finance; 1998; 24(4):7-21. PubMed ID: 9612733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Look before you launch.
    Meyer H
    Hosp Health Netw; 1998 Jan; 72(2):22, 24. PubMed ID: 9474916
    [No Abstract]   [Full Text] [Related]  

  • 10. Is your organization strategically prepared to be a Medicare PSO?
    Kelly M
    Healthc Financ Manage; 1998 May; 52(5):43-5. PubMed ID: 10179438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heading for the exits? At a time when major and regional health plans are abandoning risk contracts ...
    Med Netw Strategy Rep; 1998 Nov; 7(11):1-7. PubMed ID: 10339080
    [No Abstract]   [Full Text] [Related]  

  • 12. Medicare PSOs. Task force recommends flexibility for provider-sponsored organizations.
    Med Netw Strategy Rep; 1998 Apr; 7(4):9-10. PubMed ID: 10181286
    [No Abstract]   [Full Text] [Related]  

  • 13. How ready are health plans for Medicare?
    Gaumer G; Moore T; Friedman M; Bix B
    Eff Clin Pract; 1999; 2(1):11-6. PubMed ID: 10346548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Will Medicare provider-sponsored organizations be worth the risk?
    Larkin HD
    Med Netw Strategy Rep; 1998 Mar; 7(3):1-3. PubMed ID: 10181276
    [No Abstract]   [Full Text] [Related]  

  • 15. What it takes for big groups to succeed.
    Grandinetti DA
    Med Econ; 1997 Apr; 74(7):87-9, 93-4, 97-8. PubMed ID: 10165908
    [No Abstract]   [Full Text] [Related]  

  • 16. A practical approach for analyzing antitrust issues faced by provider networks.
    Ross DC
    J Health Hosp Law; 1997; 30(3):133-45. PubMed ID: 10179111
    [No Abstract]   [Full Text] [Related]  

  • 17. Perspectives. PSNs (provider sponsored networks): nifty concept, thorny complications.
    Cunningham R
    Faulkner Grays Med Health; 1995 Oct; 49(39):suppl 1-4. PubMed ID: 10151107
    [No Abstract]   [Full Text] [Related]  

  • 18. Medicare+Choice. A windfall without the risks.
    Haugh R
    Hosp Health Netw; 1998 Sep; 72(17):45-6. PubMed ID: 9771432
    [No Abstract]   [Full Text] [Related]  

  • 19. Network cuts cataract surgeries, boosts provider reimbursement.
    Public Sect Contract Rep; 1999 Aug; 5(8):116. PubMed ID: 10621108
    [No Abstract]   [Full Text] [Related]  

  • 20. Imitating the enemy.
    Friedman E
    Healthc Forum J; 1997; 40(4):9-11. PubMed ID: 10169565
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.